Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Carbidopa, Levodopa and Entacapone Tablets
Medication labelWhy this: Advisory · dailymed-prescription
To substitute (with equivalent strength of each of the three components) for immediate-release carbidopa/levodopa and entacapone previously administered as individual products. To replace immediate-release carbidopa/levodopa therapy (without entacapone) when patients experience the signs and symptoms of end-of-dose "wearing-off" (only for patients taking a total daily dose of levodopa of 600 mg or less and not experiencing dyskinesias, see DOSAGE AND ADMINISTRATION).
- generic_name
- carbidopa, levodopa and entacapone
- product_names
- carbidopa, levodopa and entacapone
- ndc
- 55648-782, 55648-782-02, 55648-782-03, 55648-783, 55648-783-02, 55648-783-03, 55648-784, 55648-784-02, 55648-784-03, 55648-785, 55648-785-02, 55648-785-03, 55648-786, 55648-786-02, 55648-786-03, 55648-787, 55648-787-02, 55648-787-03
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en